Atlas Trials

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection

Clinical trial NCT04834908 · TERMINATED

Trial details

NCT number
NCT04834908
Sponsor
Bharat Serums and Vaccines Limited
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
SARS-CoV-2 Infection
Start date
2021-07-27
Primary completion
2022-05-25
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.